IGF-1 LR3 Dosing: 50mcg/Day for 10 Days On

IGF-1 LR3 is a modified analog of IGF-1 with a dramatically extended half-life (20-30 hours vs minutes) and enhanced potency. It drives muscle growth through satellite cell activation and protein synthesis, but carries meaningful risks including hypoglycemia. For a full breakdown of what this peptide does, see our IGF-1 LR3 benefits guide. This is not medical advice.

Quick Reference: Standard Protocol

For GH secretagogue comparisons, see our MK-677 dosing guide and Ipamorelin dosing guide.

Cycling Details

The standard protocol is 10 consecutive days of daily injections, followed by 4 weeks off. This short, aggressive cycle is designed to maximize anabolic stimulus while minimizing risks from prolonged IGF-1 elevation.

Always have fast-acting carbohydrates available — hypoglycemia is the most immediate risk. Never inject before sleep. Start at 20 mcg for the first 2-3 days to assess tolerance, then increase to 50 mcg if well-tolerated.

Enhanced Protocol (Community)

Some advanced users run longer cycles or higher doses:

• 4-6 week cycle: 20-50 mcg daily, 4-6 weeks off (less common, higher risk)
• Bilateral IM split: 40-80 mcg/day split between muscle groups post-workout
• Training-day only: 50 mcg on training days (4-5x/week) for 4 weeks

The standard 10-day on / 4-week off cheat sheet protocol is the recommended starting point.

Routes of Administration

Subcutaneous: Abdomen or love handles. Provides systemic IGF-1 LR3 distribution. Consistent absorption, easier injection.

Intramuscular: Biceps, deltoids, quads — inject into muscles trained that day. Preferred in bodybuilding communities for theoretical local growth enhancement, though site-specific effects are debated.

Reconstitution Quick Reference

Math: 1,000 mcg / 1 mL = 1,000 mcg/mL. 50 mcg / 1,000 = 0.05 mL = 5 units. Swirl gently — IGF-1 LR3 is fragile. Some protocols use 0.6% acetic acid instead of BAC water for improved stability. Refrigerate, use within 28 days.

For step-by-step reconstitution instructions, see the BPC-157 reconstitution guide — same general technique applies.

Where These Numbers Come From

IGF-1 LR3 is a research tool and performance compound — it does not have human clinical trial data for the way it's used in the community.

IGF-1 induces muscle hypertrophy through satellite cell activation and increased protein synthesis in differentiated myofibers (Adams & McCue, 1998). LR3 IGF-1 infusion in animal models stimulates organ growth (adrenals, gut, kidneys, spleen) while suppressing endogenous IGF-1 and IGFBP levels (Bastian et al., 1993).

The LR3 modification provides a 20-30 hour half-life (vs minutes for native IGF-1), reduced IGFBP binding, and approximately 2-3x potency. Community doses of 20-80 mcg daily are extrapolated from animal research scaling, decades of bodybuilding experience, potency considerations, and risk management balancing anabolic effects against hypoglycemia (Florini et al., 1996).

Stacking Protocols

Start IGF-1 LR3 alone first. Lower LR3 doses to 20-30 mcg when stacking. Watch blood sugar closely — multiple compounds may compound hypoglycemia risk. Blood work is essential (IGF-1, glucose, insulin, HbA1c).

Side Effects & Safety

• Hypoglycemia (most immediate risk) — shaking, dizziness, sweating, confusion; always have fast-acting carbs available
• Organ growth — gut distension and cardiomegaly possible with prolonged, high-dose use
• Jaw and hand growth — subtle acromegaly-like changes with chronic use
• Cancer risk — chronically elevated IGF-1 is associated with increased cancer risk in epidemiological studies
• Joint pain — connective tissue changes, water retention
• Fatigue/lethargy — common, especially initially
• Never inject before sleep — hypoglycemia during sleep is dangerous

Frequently Asked Questions

What is the standard IGF-1 LR3 dose?

50 mcg daily (5 units from a 1 mg vial reconstituted with 1 mL BAC water) for 10 consecutive days, then 4 weeks off. Start at 20 mcg for the first few days to assess tolerance.

Should IGF-1 LR3 be injected subcutaneously or intramuscularly?

Both work. SC provides systemic distribution; IM (into trained muscles post-workout) is theorized to enhance local growth, though site-specific enhancement is debated.

How long should an IGF-1 LR3 cycle last?

The standard protocol is 10 days on, 4 weeks off. This prevents receptor desensitization and manages risks from prolonged growth factor elevation.

What are the risks of IGF-1 LR3?

Hypoglycemia (most immediate), potential organ growth with chronic use, theoretical cancer risk from prolonged IGF-1 elevation, and connective tissue changes. This is a higher-risk peptide — blood work is mandatory.

Can IGF-1 LR3 be stacked with growth hormone?

Yes, but this is advanced and risky. GH raises endogenous IGF-1, so adding exogenous LR3 creates supraphysiological levels. Use lower LR3 doses (20 mcg) if combining.

Related Guides

• IGF-1 LR3 Benefits: 5 Effects Ranked — evidence-ranked benefits with cited studies
• IGF-1 LR3 peptide page — vendor pricing and full profile
• MK-677 Dosing Guide — oral GH secretagogue for stacking
• Ipamorelin Dosing Guide — GH secretagogue with clean release profile
• BPC-157 Dosing Guide — recovery peptide to complement anabolic protocols
• Peptide Stacking Guide — principles for combining growth peptides
• Calculate Your IGF-1 LR3 Cycle Cost — estimate vials needed and total cost
• Best Peptides for Muscle Growth (2026) — all 10 muscle-building peptides ranked

References

For educational and research purposes only. This is not medical advice. IGF-1 LR3 is a research compound with no FDA approval. It carries significant risks including hypoglycemia and theoretical cancer concerns.